PEDICLE SCREW-RELATED PERJURY CHARGE AGAINST FDA'S ZELLER NOT SUPPORTED BY EVIDENCE, DoJ SAYS; REP. BARTON MAY PRESS OVERSIGHT SUBCOMMITTEE INQUIRY
This article was originally published in The Gray Sheet
The Department of Justice's decision not to pursue criminal perjury charges against FDA Deputy Associate Commissioner for Policy Mitch Zeller likely will be scrutinized by Rep. Joe Barton (R-Tex.) to determine DoJ's basis for the decision.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.